Adjunctive Corticosteroid Therapy in the Treatment of Coccidioidal Meningitis.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 28419259.
- Also identified by DOI 10.1093/cid/cix318 and PMC identifier 5850006.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Coccidioidal meningitis (CM) has high morbidity, and adjunctive measures to improve outcomes are needed. Using an established multicenter retrospective cohort study of CM (N = 221), we found that patients receiving adjunctive corticosteroids had a significant reduction in secondary cerebrovascular events (P = .0049). Those with CM-associated cerebrovascular events (8%) may benefit from short-term corticosteroids.
Medical subject headings
- Adrenal Cortex Hormones
- Coccidioidomycosis
- Meningitis, Fungal